Urecholine prophylaxis for urinary retention in anorectal surgery

Area of Science:

• Surgical outcomes
• Anesthesiology
• Pharmacology

Background:

• Postoperative urinary retention is a common complication following anorectal surgery.
• Urecholine (bethanechol) is a medication sometimes used to manage urinary retention.

Purpose of the Study:

• To evaluate the efficacy of Urecholine in preventing postoperative urinary retention and accelerating bowel function after anorectal surgery.
• To identify factors influencing postoperative urinary retention in patients undergoing anorectal procedures.

Main Methods:

• A randomized prospective trial involving 108 patients undergoing anorectal surgery.
• Comparison of oral or subcutaneous Urecholine administration versus a no-treatment control group.
• Assessment of postoperative urinary retention rates and time to first bowel movement.

Main Results:

• No significant difference in postoperative urinary retention rates was observed between Urecholine and control groups.
• Urecholine did not significantly reduce the incidence of urinary retention regardless of anesthesia type (caudal or general).
• The volume of intravenous fluids administered was a significant factor influencing postoperative urinary retention rates.

Conclusions:

• Urecholine is not effective in preventing or treating postoperative urinary retention after anorectal surgery.
• Intravenous fluid management is a critical factor to consider in mitigating urinary retention risks.
• Further research may explore alternative strategies for managing urinary dysfunction post-anorectal surgery.